The aim of our study was to assess the safety and efficacy of a CyA-to-tacrolimus conversion in a group of 14 renal transplant recipients with histology-proven CAN. Serum creatinine levels, proteinuria, and the incidence of drug side effects were monitored over a period of 1 year following CyA-to-tacrolimus conversion.
CONVERSION FROM CYCLOSPORIN TO TACROLIMUS IN CRHONIC ALLOGRAFT NEPHROPATY / Pretagostini, R., Rossi, M., Colonnello, M., Novelli, G., Berloco, P.B., S., V., R., C.. - In: TRANSPLANTATION PROCEEDINGS. - ISSN 0041-1345. - STAMPA. - 33:(2002), pp. 1025-1026. [10.1016/S0041-1345(00)02314-9]
CONVERSION FROM CYCLOSPORIN TO TACROLIMUS IN CRHONIC ALLOGRAFT NEPHROPATY
PRETAGOSTINI, Renzo;ROSSI, MASSIMO;NOVELLI, Gilnardo;BERLOCO, Pasquale Bartolomeo;
2002
Abstract
The aim of our study was to assess the safety and efficacy of a CyA-to-tacrolimus conversion in a group of 14 renal transplant recipients with histology-proven CAN. Serum creatinine levels, proteinuria, and the incidence of drug side effects were monitored over a period of 1 year following CyA-to-tacrolimus conversion.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
